Published: 2021-11-24 16:30 | Updated: 2021-11-25 10:43

Over 10MSEK from Cancerfonden to researchers at MedH

Congratulations to the four researchers at MedH who received funds from Cancerfonden 2022-2024.

Research projects granted

Mattias Carlsten, HERM

Title: "Fixing the bug: Engineering an efficient clinical immunotherapy strategy for leukemia by improving the in vivo persistence and tumor homing capacity of adoptively infused NK cells"
Funding granted: 3 000 000 kr

Karl-Johan Malmberg, CIM

Title: "A cell therapy platform based pn NKG2c+ adaptive natural killer cells"
Funding granted: 4 500 000 kr

Magnus Tobiasson, HERM

Title: "Minimal residual disease (MRD)-targeted treatment to improve outcome of allogeneic stem cell transplantation for patients with myelodysplastic syndrome"
Funding granted: 3 yr * 3 month

Petter Höglund, HERM

Title: "Platelet funcion in leukemia and immune responses to platelet transfusions: clinical and experimental studies"
Funding granted: 3 000 000 kr